EP3190128
Efnablöndur og aðferðir til meðhöndlunar ónæmisglóbúlín-miðlaðra sjúkdóma
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
17.9.2009EP published:
14.11.2018EP application number:
16170993.6
EP translation filed:
25.1.2019Grant published:
15.2.2019EPO information:
European Patent Register
Max expiry date:
16.9.2029Expiry date:
16.9.2026Next due date:
30.9.2026
Title:
COMPOSITIONS AND METHODS FOR TREATING IGE-MEDIATED DISORDERS
Timeline
Today
17.9.2009EP application
14.11.2018EP Publication
25.1.2019Translation submitted
15.2.2019Registration published
16.9.2026Expires
Owner
Name:
Xencor, Inc.Address:
111 W. Lemon Avenue, 91016, Monrovia, CA, US
Inventor
Name:
DESJARLAIS, John R.Address:
Pasadena, CA, US
Name:
CHU, Seung Y.Address:
Cypress, CA, US
Name:
HORTON, Holly M.Address:
Acton, MA, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
97819 PDate:
17.9.2008Country:
US
Classification
Categories:
C07K 16/42, A61K 39/395, A61P 37/08
Annual fees
Number
Paid
Expires
Payer
Number: 11
Paid: 1.9.2019
Expires: 16.9.2020
Payer: Sigurjónsson & Thor ehf.
Number: 12
Paid: 6.8.2020
Expires: 16.9.2021
Payer: Árnason Faktor ehf.
Number: 13
Paid: 10.8.2021
Expires: 16.9.2022
Payer: Árnason Faktor ehf.
Number: 14
Paid: 22.8.2022
Expires: 16.9.2023
Payer: Árnason Faktor ehf.
Number: 15
Paid: 5.9.2023
Expires: 16.9.2024
Payer: Árnason Faktor ehf.
Number: 16
Paid: 17.9.2024
Expires: 16.9.2025
Payer: Árnason Faktor ehf.
Number: 17
Paid: 15.9.2025
Expires: 16.9.2026
Payer: Árnason Faktor ehf.